Moderna's Personalized mRNA Cancer Vaccine Succeeds in Phase 3; Shares Soar 176% Intraday

This is evident in the fact that three members demanded a 0.25 percentage point rate hike even though the benchmark rate was held steady.

At this FOMC meeting, a proposal to reduce the number of regular meetings was newly discussed. The current eight meetings per year would be cut to six, held roughly once every two months. The aim is to lengthen the interval between meetings to gather more data needed for policy decisions.

The U.S. Treasury decided to more than double the size of its bond buybacks to stabilize the market. It plans to focus purchases on long-term Treasuries from 10-year to 30-year maturities, raising the per-operation buyback size from the previous $2 billion to at least $4 billion, with full implementation starting next month.

Former President Donald Trump said at a meeting with leaders from the finance and cryptocurrency industries that the U.S. must firmly hold first place in future technologies, including artificial intelligence (AI) and Bitcoin. He emphasized securing technological leadership, including a strategic Bitcoin reserve. In particular, Trump argued that strong economic growth does not necessarily lead directly to inflation, so current high interest rates should rightly come down.

This is the first time a personalized mRNA therapy has demonstrated clear therapeutic efficacy at the final stage of clinical testing. Following the news, Moderna's shares more than doubled intraday, and combined market capitalization rose by $50 billion.

Sarah Friar, OpenAI's Chief Financial Officer, formalized through an all-hands meeting the projection that the company would become a listed firm around 2027, though the listing could be accelerated if its earnings rebound continues. Friar explained that an IPO is not simply a finish line but a milestone for raising capital, and that proving the company's value comes first.